A guide to enteral drug administration in palliative care

Journal of Pain and Symptom Management

Volumn 17, Issue 3, 1999, Pages 197-207

  Gilbar, Peter J ^a  

^a TOOWOOMBA HOSPITAL   (Australia)

Author keywords

Compatibility; Drug absorption; Drug administration; Drug clearance; Enteral feeding; Guidelines; Oral dosage form; Palliative care

Indexed keywords

DRUG;

ANOREXIA; ARTICLE; CANCER PALLIATIVE THERAPY; DRUG ABSORPTION; DYSPHAGIA; ENTERIC FEEDING; HUMAN; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; TREATMENT INDICATION; METHODOLOGY; PALLIATIVE THERAPY; REVIEW;

ADMINISTRATION, ORAL; ENTERAL NUTRITION; HUMANS; PALLIATIVE CARE; PHARMACEUTICAL PREPARATIONS;

EID: 0032586995     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(98)00124-9     Document Type: Article

References (57)

1. Kirby D.F., Delegge M.H., Fleming C.R. American Gastroenterological Association technical review on tube feeding for enteral nutrition. Gastroenterology. 108:1995;1282-1301.
2. Queensland Hospitals Drug Advisory Committee. Guide to enteral nutrition. Queensland Health, Brisbane, Australia, 1994:1-27.
3. Keymling M. Technical aspects of enteral feeding. Gut. suppl 1):1994;S77-S80.
4. Ripamonti C., Gemlo B.T., Bozzetti F., De Conno F. Role of enteral nutrition in advanced cancer patients. indications and contraindications of the different techniques employed Tumori. 82:1996;302-308.
5. Bozzetti F. Is enteral nutrition a primary therapy in cancer patients? Gut. Suppl 1):1994;S65-S68.
6. Cozzaglio L., Bozzetti F. Does parenteral nutrition increase tumor growth? A review. Tumori. 80:1994;169-174.
7. Ottery F.D. Rethinking nutritional support of the cancer patient. the new field of nutritional oncology Semin Oncol. 21:1994;770-778.
8. Howard L. Home parenteral and enteral nutrition in cancer patients. Cancer. 72:1993;3531-3541.
9. Bloch A.S., Brown P. Methods of nutritional support in the home. J Pain Symptom Manage. 5:1990;297-306.
10. Gilbar P.J., Kam F.S.F. Guidelines for drug administration during enteral feeding. Aust J Hosp Pharm. 27:1997;214-220.
11. Mitchell J.F. Oral solid dosage forms that should not be crushed. 1996 revision Hosp Pharm. 31:1996;27-37.
12. Birdsall C, Uretsky S. How do I administer medication by NG? Am J Nurs 1984;84:1259-1260, 1284.
13. Powers J.E., Cascella P.J. Comparison of methods used to prepare tablets for nasogastric tube administration. J Pharm Technol. 6:1990;60-62.
14. Martin T.P., Hayes P., Collins D.M. Tablet dispersion as an alternative to formulation of oral liquid dosage forms. Aust J Hosp Pharm. 23:1993;378-381.
15. McPherson M.L. Don't crush that tablet. Am Pharm. NS34(5):1994;57-58.
16. Balaban D.H., Duckworth C.W., Peura D.A. Nasogastric omeprazole. effects on gastric pH in critically ill patients Am J Gastroenterol. 92:1997;79-83.
17. Sharma V.K., Heinzelmann E.J., Steinberg E.N., Vasudeva R., Howded C.W. Nonencapsulated, intact omeprazole granules effectively suppress intragastric acidity when administered via a gastrostomy. Am J Gastroenterol. 92:1997;848-851.
18. Jones R., Hale E., Talomsin L., Phillips R. Kapanol capsules. pellet formulation provides alternative methods of administration of sustained-release morphine sulfate Clin Drug Invest. 12:1996;88-93.
19. Greenwood J., Brown G. Sorbitol-induced diarrhea in a tube-fed patient. Can J Hosp Pharm. 11:1991;378-387.
20. Bauer L.A. Interference of oral phenytoin absorption by continuous nasogastric feeding. Neurology. 32:1982;570-572.
21. Worden J.P. Jr., Wood C.A. Jr., Workman C.H. Phenytoin and nasogastric feedings [letter]. Neurology. 34:1984;132.
22. Saklad J.J., Graves R.H., Sharp W.P. Interaction of oral phenytoin with enteral feedings. JPEN J Parenter Enteral Nutr. 10:1986;322-323.
23. Longe R.L., Smith O.B. Phenytoin interaction with oral feeding results in loss of seizure control. J Am Geriatr Soc. 36:1988;542-544.
24. Pearce G.A. Apparent inhibition of phenytoin absorption by an enteral nutrient formula. Aust J Hosp Pharm. 18:1988;289-292.
25. Weinryb J., Cogen R. Interaction of nasogastric phenytoin and enteral feeding solution [letter]. J Am Geriatr Soc. 37:1989;195-196.
26. Rodman D.P., Stevenson T.L., Ray T.R. Phenytoin malabsorption after jejunostomy tube delivery. Pharmacotherapy. 15:1995;801-805.
27. Hooks M.A., Longe R.L., Taylor A.T., Francisco G.E. Recovery of phenytoin from an enteral nutrition formula. Am J Hosp Pharm. 43:1986;685-688.
28. Smith O.B., Longe R.L., Altman R.E., Price J.C. Recovery of phenytoin from solutions of caseinate salts and calcium chloride. Am J Hosp Pharm. 45:1988;365-368.
29. Haley C.J., Nelson J. Phenytoin-enteral feeding interaction. DICP. 23:1989;796-798.
30. Randall T.C., Tett S.C. Phenytoin pharmacokinetics after intravenous administration to patients receiving enteral tube feeding. Pharm World Sci. 16:1994;217-224.
31. Ingebretson M.C., Pucino F., Beck C.L., Strommen G.L.et al. Continuous nasogastric morphine infusion. Drug Intell Clin Pharm. 21:1987;796-797.
32. Michelini T.J., Bhargava V.O., DuBe J.E. Stability of oral morphine sulfate solution in two enteral tube feeding products. Am J Hosp Pharm. 45:1988;628-630.
33. Udeani G.O., Bass J., Johnston T.P. Compatibility of oral morphine sulfate solution with enteral feeding products. Ann Pharmacother. 28:1994;451-455.
34. Valli C., Schulthess H.K., Asper R., Escher F., Hacki W.H. Interaction of nutrients with antacids. a complication during enteral tube feeding [letter] Lancet. 329:1986;747-748.
35. Gal P., Layson R. Interference with oral theophylline absorption by continuous nasogastric feedings. Ther Drug Monit. 8:1986;421-423.
36. Anderson W., Weatherstone G., Veal C. Esophageal medication bezoar in a patient receiving enteral feedings and sucralfate. Am J Gastroenterol. 84:1989;205-206.
37. Healy D.P., Broderick M.C., Clendening C.E. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes. Antimicrob Agents Chemother. 40:1996;6-10.
38. Mueller B.A., Brierton D.G., Abel S.R., Bowman L. Effect of enteral feeding with Ensure on oral bioavailabilities of ofloxacin and ciprofloxacin. Antimicrob Agents Chemother. 38:1994;2101-2105.
39. Piccolo M.L., Toossi Z., Goldman M. Effect of coadministration of a nutritional supplement on ciprofloxacin absorption. Am J Hosp Pharm. 51:1994;2697-2699.
40. Yuk J.H., Nightingale C.H., Sweeney K.R., Quintilianni R., Lettieri J.T., Frost R.W. Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding. Antimicrob Agents Chemother. 33:1989;1118-1120.
41. Kuhn T.A., Garnett W.R., Wells B.K., Karnes H.T. Recovery of warfarin from an enteral nutrient formula. Am J Hosp Pharm. 46:1989;1395-1399.
42. Martin J.E., Lutomski D.M. Warfarin resistance and enteral feedings. JPEN J Parenter Enteral Nutr. 13:1989;206-208.
43. Petretich D.A. Reversal of osmolite-warfarin interaction by changing warfarin administration time [letter]. Clin Pharm. 9:1990;93.
44. Strom J.G. Jr., Miller S.W. Stability of drugs with enteral nutrient formulas. DICP. 24:1990;130-134.
45. Randall C., Tett S.E. Carbamazepine plasma concentrations. the effects of enteral feeding, concomitant phenytoin therapy and other factors Aust J Hosp Pharm. 23:1993;388-391.
46. Nicolau D.P., Crowe H., Nightingale C.H., Quintilianni R. Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients. J Antimicrob Chemother. 36:1995;395-401.
47. Crowther R.S., Bellanger R., Szauter K.E.M. In vitro stability of ranitidine hydrochloride in enteral nutrient formulas. Ann Pharmacother. 29:1995;859-862.
48. Holtz L., Milton J., Sturek J.K. Compatibility of medications with enteral feedings. JPEN J Parenter Enteral Nutr. 11:1987;183-186.
49. Parker W.A. Pharmaceutical considerations of drugs and enteral feedings [letter]. Can J Hosp Pharm. 38:1985;119.
50. Niemec P.W., Vanderveen T.W., Morrison J.I., Hohenwarter M.W. Gastrointestinal disorders caused by medication and electrolyte solution osmolality during enteral nutrition. JPEN J Parenter Enteral Nutr. 7:1983;387-389.
51. Benson H.A.E., Prankerd R.J. Optimisation of drug delivery 4. Transdermal drug delivery. Aust J Hosp Pharm. 27:1997;441-448.
52. Warren D.E. Practical use of rectal medications in palliative care. J Pain Symptom Manage. 11:1996;378-387.
53. Cacek A.T., DeVito J.M., Koonce J.R. In vitro evaluation of nasogastric administration methods for phenytoin. Am J Hosp Pharm. 43:1986;689-692.
54. Clark-Schmidt A.L., Garnett W.R., Lowe D.R., Karnes H.T. Loss of carbamazepine suspension through nasogastric feeding tubes. Am J Hosp Pharm. 47:1990;2034-2037.
55. Nicolau D.P., Davis S.K. Carbonated beverages as irrigants for feeding tubes. DICP. 24:1990;840.
56. Caswell A. MIMS Annual 1997, 21st ed. 1997;MIMS Australia, Sydney.
57. McEvoy G.K. AHFS 97 Drug information. 1997;American Society of Health-System Pharmacists, Bethesda, MD.